UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 25, 2022 4:01 P.M.

Form:	S-3
CIK: 0001827506 Company Name: Talaris Therapeutics, Inc. File Number: 333-266875